Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.45
LHCG's Cash to Debt is ranked higher than
58% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 0.30 vs. LHCG: 0.45 )
Ranked among companies with meaningful Cash to Debt only.
LHCG' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.50 Max: No Debt
Current: 0.45
Equity to Asset 0.66
LHCG's Equity to Asset is ranked higher than
79% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. LHCG: 0.66 )
Ranked among companies with meaningful Equity to Asset only.
LHCG' s 10-Year Equity to Asset Range
Min: 0.34  Med: 0.73 Max: 0.82
Current: 0.66
0.34
0.82
Interest Coverage 18.30
LHCG's Interest Coverage is ranked higher than
65% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 6.48 vs. LHCG: 18.30 )
Ranked among companies with meaningful Interest Coverage only.
LHCG' s 10-Year Interest Coverage Range
Min: 7.98  Med: 23.43 Max: 713.45
Current: 18.3
7.98
713.45
F-Score: 6
Z-Score: 5.63
M-Score: -2.73
WACC vs ROIC
9.02%
10.13%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.26
LHCG's Operating margin (%) is ranked higher than
51% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 7.11 vs. LHCG: 7.26 )
Ranked among companies with meaningful Operating margin (%) only.
LHCG' s 10-Year Operating margin (%) Range
Min: -1.01  Med: 14.29 Max: 19.53
Current: 7.26
-1.01
19.53
Net-margin (%) 3.55
LHCG's Net-margin (%) is ranked higher than
52% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 3.47 vs. LHCG: 3.55 )
Ranked among companies with meaningful Net-margin (%) only.
LHCG' s 10-Year Net-margin (%) Range
Min: -2.09  Med: 6.25 Max: 10.95
Current: 3.55
-2.09
10.95
ROE (%) 8.59
LHCG's ROE (%) is ranked lower than
51% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 8.83 vs. LHCG: 8.59 )
Ranked among companies with meaningful ROE (%) only.
LHCG' s 10-Year ROE (%) Range
Min: -4.93  Med: 20.56 Max: 178.18
Current: 8.59
-4.93
178.18
ROA (%) 5.53
LHCG's ROA (%) is ranked higher than
62% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.60 vs. LHCG: 5.53 )
Ranked among companies with meaningful ROA (%) only.
LHCG' s 10-Year ROA (%) Range
Min: -3.51  Med: 13.28 Max: 24.69
Current: 5.53
-3.51
24.69
ROC (Joel Greenblatt) (%) 57.15
LHCG's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. LHCG: 57.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
LHCG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4.82  Med: 64.53 Max: 158.2
Current: 57.15
-4.82
158.2
Revenue Growth (3Y)(%) 6.90
LHCG's Revenue Growth (3Y)(%) is ranked lower than
56% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. LHCG: 6.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
LHCG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 3.5  Med: 26.30 Max: 60.8
Current: 6.9
3.5
60.8
EBITDA Growth (3Y)(%) 171.40
LHCG's EBITDA Growth (3Y)(%) is ranked higher than
98% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.60 vs. LHCG: 171.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
LHCG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -64.8  Med: 29.10 Max: 171.4
Current: 171.4
-64.8
171.4
» LHCG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

LHCG Guru Trades in Q3 2014

Jim Simons 67,200 sh (-16.85%)
» More
Q4 2014

LHCG Guru Trades in Q4 2014

Jim Simons 112,400 sh (+67.26%)
» More
Q1 2015

LHCG Guru Trades in Q1 2015

Jim Simons 141,198 sh (+25.62%)
» More
Q2 2015

LHCG Guru Trades in Q2 2015

Chuck Royce 1,100 sh (New)
Jim Simons 91,200 sh (-35.41%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.69
LHCG's P/E(ttm) is ranked lower than
54% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. LHCG: 27.69 )
Ranked among companies with meaningful P/E(ttm) only.
LHCG' s 10-Year P/E(ttm) Range
Min: 6.45  Med: 17.83 Max: 33.22
Current: 27.69
6.45
33.22
Forward P/E 22.99
LHCG's Forward P/E is ranked lower than
73% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 19.76 vs. LHCG: 22.99 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 28.80
LHCG's PE(NRI) is ranked lower than
51% of the 149 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. LHCG: 28.80 )
Ranked among companies with meaningful PE(NRI) only.
LHCG' s 10-Year PE(NRI) Range
Min: 6.38  Med: 17.52 Max: 32.35
Current: 28.8
6.38
32.35
P/B 2.26
LHCG's P/B is ranked higher than
56% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. LHCG: 2.26 )
Ranked among companies with meaningful P/B only.
LHCG' s 10-Year P/B Range
Min: 0.88  Med: 2.01 Max: 4.66
Current: 2.26
0.88
4.66
P/S 0.98
LHCG's P/S is ranked higher than
66% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. LHCG: 0.98 )
Ranked among companies with meaningful P/S only.
LHCG' s 10-Year P/S Range
Min: 0.35  Med: 0.87 Max: 2.36
Current: 0.98
0.35
2.36
PFCF 14.46
LHCG's PFCF is ranked higher than
70% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.04 vs. LHCG: 14.46 )
Ranked among companies with meaningful PFCF only.
LHCG' s 10-Year PFCF Range
Min: 3.89  Med: 11.89 Max: 112.88
Current: 14.46
3.89
112.88
POCF 12.11
LHCG's POCF is ranked higher than
61% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 15.33 vs. LHCG: 12.11 )
Ranked among companies with meaningful POCF only.
LHCG' s 10-Year POCF Range
Min: 3.67  Med: 9.48 Max: 150.5
Current: 12.11
3.67
150.5
EV-to-EBIT 14.32
LHCG's EV-to-EBIT is ranked higher than
68% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. LHCG: 14.32 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s 10-Year EV-to-EBIT Range
Min: -59.5  Med: 9.10 Max: 162.4
Current: 14.32
-59.5
162.4
Shiller P/E 30.23
LHCG's Shiller P/E is ranked lower than
55% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.72 vs. LHCG: 30.23 )
Ranked among companies with meaningful Shiller P/E only.
LHCG' s 10-Year Shiller P/E Range
Min: 7.67  Med: 13.24 Max: 35.26
Current: 30.23
7.67
35.26
Current Ratio 2.00
LHCG's Current Ratio is ranked higher than
74% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. LHCG: 2.00 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s 10-Year Current Ratio Range
Min: 1.65  Med: 2.19 Max: 4.45
Current: 2
1.65
4.45
Quick Ratio 2.00
LHCG's Quick Ratio is ranked higher than
79% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. LHCG: 2.00 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s 10-Year Quick Ratio Range
Min: 1.65  Med: 2.19 Max: 4.45
Current: 2
1.65
4.45
Days Sales Outstanding 47.20
LHCG's Days Sales Outstanding is ranked lower than
52% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 46.03 vs. LHCG: 47.20 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s 10-Year Days Sales Outstanding Range
Min: 46.27  Med: 52.51 Max: 85.77
Current: 47.2
46.27
85.77

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 45.03
LHCG's Price/Tangible Book is ranked lower than
100% of the 143 Companies
in the Global Medical Care industry.

( Industry Median: 3.64 vs. LHCG: 45.03 )
Ranked among companies with meaningful Price/Tangible Book only.
LHCG' s 10-Year Price/Tangible Book Range
Min: 4.47  Med: 8.75 Max: 91.75
Current: 45.03
4.47
91.75
Price/Projected FCF 1.12
LHCG's Price/Projected FCF is ranked higher than
71% of the 100 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. LHCG: 1.12 )
Ranked among companies with meaningful Price/Projected FCF only.
LHCG' s 10-Year Price/Projected FCF Range
Min: 0.34  Med: 0.53 Max: 0.98
Current: 1.12
0.34
0.98
Price/Median PS Value 1.13
LHCG's Price/Median PS Value is ranked lower than
54% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.11 vs. LHCG: 1.13 )
Ranked among companies with meaningful Price/Median PS Value only.
LHCG' s 10-Year Price/Median PS Value Range
Min: 0.43  Med: 1.00 Max: 2.71
Current: 1.13
0.43
2.71
Price/Graham Number 6.49
LHCG's Price/Graham Number is ranked lower than
92% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. LHCG: 6.49 )
Ranked among companies with meaningful Price/Graham Number only.
LHCG' s 10-Year Price/Graham Number Range
Min: 1.46  Med: 2.47 Max: 23.05
Current: 6.49
1.46
23.05
Earnings Yield (Greenblatt) (%) 6.95
LHCG's Earnings Yield (Greenblatt) (%) is ranked higher than
74% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. LHCG: 6.95 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
LHCG' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.6  Med: 10.30 Max: 25.8
Current: 6.95
0.6
25.8
Forward Rate of Return (Yacktman) (%) -20.36
LHCG's Forward Rate of Return (Yacktman) (%) is ranked lower than
92% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 11.17 vs. LHCG: -20.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
LHCG' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -14  Med: 12.60 Max: 42.7
Current: -20.36
-14
42.7

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 791 838
EPS($) 1.73 1.90
EPS without NRI($) 1.73 1.90

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:LH6.Germany,
LHC Group Inc was incorporated on February 9, 2005. The Company provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals (LTACHs). The Company through its wholly- and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operates in 30 states within the continental United States. The Company operates in three segments: home-based services, hospice services and facility-based services. In the home-based services segment, the Company provides home-based post-acute health care services through its home nursing and community-based agencies. Its service locations offer services, including skilled nursing, community-based nursing and companion services, non-skilled community-based services (CBS), medically-oriented social services and physical, occupational and speech therapy. The hospices segment provides end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors and volunteers. It offers services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The LTACH locations provide services to patients with complex medical conditions who have transitioned out of a hospital intensive care unit but whose conditions remain too severe for treatment in a non-acute setting. The Company is subject to federal, state and local laws, which significantly affects its business.
» More Articles for LHCG

Headlines

Articles On GuruFocus.com
Intelligent (and Unintelligent) Investing: Part 1 Jun 03 2015 
“Powerball” Ideas - Home Healthcare Companies: AFAM, GTIV, LHCG, AMED Jan 05 2012 
posible buy Aug 24 2011 
DCF Jul 24 2011 
LHC Group Reports Operating Results (10-K) Mar 10 2011 
LHC Group Reports Operating Results (10-Q) Nov 03 2010 
LHC Group Reports Operating Results (10-Q) Aug 06 2010 
LHC Group (LHCG) CFO Peter J. Roman sells 1,200 Shares May 27 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 169,800 Shares May 13 2010 
LHC Group (LHCG) CEO and President, 10% Owner Keith G Myers sells 5,200 Shares May 12 2010 

More From Other Websites
LHC Group, Inc. Q2 Earnings, 2015 Aug 25 2015
South Carolina Hospice and Palliative Care celebrates a new location Aug 24 2015
LHC GROUP, INC Financials Aug 18 2015
Coliseum Capital’s Latest Moves Include New Position, More Profit Taking Aug 15 2015
Liberator Medical Holdings, Inc.: Sudden move in price, will it continue? Aug 12 2015
10-Q for LHC Group, Inc. Aug 08 2015
LHC GROUP, INC Files SEC form 10-Q, Quarterly Report Aug 06 2015
Edited Transcript of LHCG earnings conference call or presentation 6-Aug-15 3:00pm GMT Aug 06 2015
LHC Group Inc Earnings Call scheduled for 11:00 am ET today Aug 06 2015
LHC Group announces second quarter 2015 results and raises full year 2015 guidance Aug 05 2015
LHC GROUP, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 05 2015
LHC Group Announces Second Quarter 2015 Results and Raises Full Year 2015 Guidance Aug 05 2015
Q2 2015 LHC Group Inc Earnings Release - After Market Close Aug 05 2015
LHC Group announces second quarter 2015 earnings release and conference call dates Jul 22 2015
Elite Home Health earns accreditation from The Joint Commission Jul 22 2015
Georgia Home Health earns accreditation from The Joint Commission Jul 22 2015
LHC Group Announces Second Quarter 2015 Earnings Release and Conference Call Dates Jul 22 2015
Colorado Springs home health agency undergoes name change Jun 15 2015
LHC GROUP, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 12 2015
Coliseum Capital Takes Some Profit From Its LHC Group, Inc. (LHCG) Holding; More On The Way? Jun 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK